The CYTK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CYTK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CYTK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View CYTK Detailed Price Forecast - CNN Money | View CYTK Detailed Summary - Google Finance | ||
View CYTK Detailed Summary - Yahoo! Finance | View CYTK Stock Research & Analysis - Zacks.com |
View CYTK Trends & Analysis - Trade-Ideas | View CYTK Major Holders - Barrons | ||
View CYTK Call Transcripts - NASDAQ | View CYTK Breaking News & Analysis - Seeking Alpha | ||
View CYTK Annual Report - CompanySpotlight.com | View CYTK OTC Short Report - OTCShortReport.com | ||
View CYTK Fundamentals - TradeKing | View CYTK SEC Filings - Bar Chart | ||
View Historical Prices for CYTK - The WSJ | View Performance/Total Return for CYTK - Morningstar | ||
View the Analyst Estimates for CYTK - MarketWatch | View the Earnings History for CYTK - CNBC | ||
View the CYTK Earnings - StockMarketWatch | View CYTK Buy or Sell Recommendations - MacroAxis | ||
View the CYTK Bullish Patterns - American Bulls | View CYTK Short Pain Metrics - ShortPainBot.com |
View CYTK Stock Mentions - StockTwits | View CYTK Stock Mentions - PennyStockTweets | ||
View CYTK Stock Mentions - Twitter | View CYTK Investment Forum News - Investor Hub | ||
View CYTK Stock Mentions - Yahoo! Message Board | View CYTK Stock Mentions - Seeking Alpha |
View Insider Transactions for CYTK - SECform4.com | View Insider Transactions for CYTK - Insider Cow | ||
View CYTK Major Holdings Summary - CNBC | View Insider Disclosure for CYTK - OTC Markets | ||
View Insider Transactions for CYTK - Yahoo! Finance | View Institutional Holdings for CYTK - NASDAQ |
View CYTK Stock Insight & Charts - FinViz.com | View CYTK Investment Charts - StockCharts.com | ||
View CYTK Stock Overview & Charts - BarChart | View CYTK User Generated Charts - Trading View |
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
Posted on Wednesday April 10, 2024
GLP-1 medications will likely expand beyond their current uses for diabetes or weight loss, according to money managers at Tema
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Posted on Wednesday April 10, 2024
Primary Results from SEQUOIA-HCM to Elaborate on Positive Topline Results in Patients with Obstructive Hypertrophic Cardiomyopathy Two Additional Analyses from SEQUOIA-HCM Assess Effect of Aficamten on Exercise Capacity and Dosing and Safety SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three Late Breaking Clinical Trial presentations relating to SEQUOIA-HCM, (Safety, Efficacy, and Quantitative Understanding of Obstructi
EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
Posted on Tuesday April 09, 2024
Cytokinetics Inc (NASDAQ:CYTK), a biopharmaceutical company focused on the discovery and development of next-generation therapeutics for muscle diseases, has reported an insider sale according to a recent SEC filing.
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
Posted on Friday April 05, 2024
Treatment with Aficamten for 48 Weeks is Associated with Improvements in Clinical Efficacy Endpoints, NYHA Class and Cardiac Biomarkers, Structure and FunctionSOUTH SAN FRANCISCO, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced additional 48-week data from FOREST-HCM (Follow-up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten in HCM), the open label extension clinical study of aficamten in patients with hypertrophic cardi